Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children.
David SchnadowerPhillip I TarrT Charles CasperMarc H GorelickJ Michael DeanKaren J O'ConnellPrashant MahajanAdam C LevineSeema R BhattCindy G RoskindElizabeth C PowellAlexander J RogersCheryl VanceRobert E SapienCody S OlsenMelissa MetheneyViani P DickeyCarla Hall-MooreStephen B FreedmanPublished in: The New England journal of medicine (2018)
Among preschool children with acute gastroenteritis, those who received a 5-day course of L. rhamnosus GG did not have better outcomes than those who received placebo. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; ClinicalTrials.gov number, NCT01773967 .).
Keyphrases
- endothelial cells
- liver failure
- double blind
- phase iii
- young adults
- quality improvement
- respiratory failure
- induced pluripotent stem cells
- pluripotent stem cells
- placebo controlled
- drug induced
- aortic dissection
- clinical trial
- intensive care unit
- adipose tissue
- extracorporeal membrane oxygenation
- insulin resistance
- acute respiratory distress syndrome